Editorial on“Perihilar Cholangiocarcinoma-Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers”  

作　　者：Shivan Sivakumar Flavio GRocha Lara Heij 

机构地区：[1]Department of Oncology,University of Oxford,Oxford,UK [2]Division of Surgical Oncology,Knight Cancer Institute,Oregon Health and Science University,Portland,OR,USA [3]Department of Surgery and Transplantation,University Hospital RWTH Aachen,Aachen,Germany [4]Institute of Pathology,University Hospital RWTH Aachen,Aachen,Germany

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第3期422-424,共3页肝胆外科与营养（英文）

摘　　要：Cholangiocarcinoma(CCA)is a rare and very aggressive malignancy arising from the biliary tract.Based on the location of the tumor,CCA can be divided in intrahepatic cholangiocarcinoma(iCCA),perihilar cholangiocarcinoma(pCCA)and distal cholangiocarcinoma(dCCA).Many other characteristics differentiate these groups,including pathological features,oncological approach and surgical techniques,which in turn influences patient outcomes.

关 键 词：HILAR carcinoma SURGICAL 

分 类 号：R73[医药卫生—肿瘤]